Running a hospital (Free subscription) | 6 hours ago
Medical grand rounds at BIDMC today consisted of a presentation by Dave deBronkart (aka e-Patient Dave ) and his primary care doctor, Danny Sands (seen here with Chief of Medicine Mark Zeidel.) Back in January 2007, Dave went in for a routine radiology study. As he noted a few days later on his CaringBridge site: On January 2, 2007 a routine shoulder x-ray showed a mass in a nearby part of my lung....
Covering Health (Free subscription) | 11/26/2009
AHCJ member Laura Newman, the About.com guide to urology, writes about whether consumers will embrace the message that "'less is more,' when science confirms it." In this case, Newman focuses on the American Urological Association's guideline for kidney cancer treatment, released in April, that called for saving the kidney whenever ...
Flesh and Stone (Free subscription) | 11/24/2009
Six Minnesotans are suing Gov. Tim Pawlenty over his decision this past summer to cut (or “unallot”) $5.3 million from a special dietary program that covered 5,072 residents. Last week, members of the state House of Representatives Rules Committee voted to file an amicus brief in support of the class action suit. The legal actions assert that the governor’s unallotment was unconstitutional...
Medical News Today (Free subscription) | 11/23/2009
Antigenics Inc. (NASDAQ: AGEN) announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has formally adopted a negative opinion on the marketing authorization application (MAA) for Oncophage (vitespen) as a treatment in earlier-stage, localized renal cell carcinoma (kidney cancer).
Seattle Times (Free subscription) | 11/20/2009
Biotechnology company Antigenics Inc. said Friday it will not seek approval for a potential kidney cancer treatment after a European advisory committee recommended against approving the drug candidate.
Seattle Post-Intelligencer (Free subscription) | 11/20/2009
LEXINGTON, Mass. -- Biotechnology company Antigenics Inc. said Friday it will not seek approval for a potential kidney cancer treatment after a European advisory committee recommended against approving the drug candidate.
Business Wire (Free subscription) | 11/20/2009
LONDON--(BUSINESS WIRE)--Antigenics Inc. (NASDAQ: AGEN) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has formally adopted a negative opinion on the marketing authorization application (MAA) for Oncophage (vitespen) as a treatment in earlier-stage, localized renal cell carcinoma (kidney cancer). A negative...
Eurekalert (Free subscription) | 11/19/2009
( European Association of Urology ) Urological cancer patients will benefit greatly if the delivered treatment is the result of a combined effort. Collaboration of experts from various fields is necessary to take cancer-related research and medical practice to the next level. The 2nd European Multidisciplinary Meeting on Urological Cancers -- Embracing Excellence in Prostate, Bladder and Kidney Cancer...
Gold-Plated Witch on Wheels (Free subscription) | 11/12/2009
Chuck has posted several links to examples of the great care one receives from socialized medicine: Cancer survivor confronts the health secretary on 62-day wait The current target of 62 days from urgent referral by a doctor to starting treatment has still not been met in Scotland, despite that originally being the target figure for 2005. Girl, 3, has heart operation cancelled three times because of...
NewsBusters (Free subscription) | 11/11/2009
On Monday night’s All Things Considered newscast on National Public Radio, reporter Joseph Shapiro recounted the sympathetic story of Regina Holliday, who lost her 39-year-old husband Fred to kidney cancer. Holliday painted a mural in Washington demanding "We Need Health Reform Now." (It’s headlined "A Widow Paints a Health Care Protest" and it's the most popular story...
Pinoy Healthcare (Free subscription) | 11/11/2009
Colon cancer is cancer of the large intestine (colon), the lower part of your digestive system. Colon cancer is the second most common cancer in the USA with equal distribution between men and women. Colon tumors usually affect people over the age of 40, with the majority of people who are diagnosed with the condition [...] Related Posts Bone Cancer: Causes, Symptoms, Diagnosis, Treatment and Prognosis...
Pinoy Healthcare (Free subscription) | 11/11/2009
Determining the ****** cancer stages is important since it enables the patient and doctor to identify the treatment necessary for one’s condition. Also, it is essential in assessing the risk of the given condition and what lifestyle changes the patient can do to improve their health.Identifying A ****** Cancer’s StageWhen talking about ****** cancer stages, [...] Related Posts Breast Cancer...
Pinoy Healthcare (Free subscription) | 11/10/2009
Do you find yourself searching for facts about ovarian cancer?Well here are a couple quick facts for you.The ovaries belong to the female reproductive system and produce eggs each month during the reproductive years of a woman. You will find that they are located on either side of the woman’s lower abdomen. Ovarian cancer occurs [...] Related Posts Ovarian Cancer - Don’t Ignore the Warning...
Nature Publishing Group (Free subscription) | 11/05/2009
Tyrosine kinase inhibitors delay tumor progression and have a favorable adverse effect profile in patients with metastatic renal cell carcinoma; however, the impact of these treatments on objective clinical outcomes remains unknown. Updated results from two landmark phase III randomized trials now demonstrate the effect of sunitinib and sorafenib on survival.
PR News Wire (Free subscription) | 11/03/2009
EMERYVILLE, Calif., Nov. 3 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today reported its financial results for the third quarter 2009. Global Nexavar net sales as reported by Onyx's collaborator Bayer HealthCare Pharmaceuticals, or Bayer, were $229.2 million for the third quarter 2009, a 27% increase compared to $180.9 million in the same period in 2008. Onyx and Bayer are...
The 3 latest articles published by users on Kidney Cancer :
aarkstore | 10/28/2009
Kidney Cancer Therapy Area Pipeline Report contains detailed information on the kidney cancer drug pipeline. This report provides insight into the pipeline status of kidney cancer drugs by company and by stage as well as a summary of the latest news and developments in this area. Scope of the report: Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug...
Lisa Lisa | 12/26/2008
Kidney Failure - Chronic Renal Failure Read on to know more about the various causes of chronic renal failure, symptoms of kidney failure, and methods to prevent kidney failure… The Kidneys are a pair of bean shaped organs in the body. Their func...
Lisa Lisa | 12/25/2008
Kidney Cancer Symptoms Every year around 200,000 to 250,000 people are diagnosed with and around 40,000 lose their lives to this disease… Kidney is one of the most important organs that act as natural refinery; remove waste from blood ...
Videos